102 related articles for article (PubMed ID: 23592163)
1. Surgeon leadership enables development of a colorectal cancer biorepository.
Tsikitis VL; Lu KC; Douthit M; Herzig DO
Am J Surg; 2013 May; 205(5):563-5; discussion 565. PubMed ID: 23592163
[TBL] [Abstract][Full Text] [Related]
2. Variance of surgeons versus pathologists in staging of colorectal cancer.
Jha MK; Corbett WA; Wilson RG; Koreli A; Papagrigoriadis S
Minerva Chir; 2006 Oct; 61(5):385-91. PubMed ID: 17159746
[TBL] [Abstract][Full Text] [Related]
3. Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view.
Huber J; Herpel E; Jakobi H; Hadaschik BA; Pahernik S; Hohenfellner M
Urol Oncol; 2013 Oct; 31(7):990-6. PubMed ID: 22386623
[TBL] [Abstract][Full Text] [Related]
4. Surgeon and hospital volume and the management of colorectal cancer patients in Australia.
McGrath DR; Leong DC; Gibberd R; Armstrong B; Spigelman AD
ANZ J Surg; 2005 Oct; 75(10):901-10. PubMed ID: 16176237
[TBL] [Abstract][Full Text] [Related]
5. Progressive Consent and Specimen Accrual Models to Address Sustainability: A Decade's Experience at an Oregon Biorepository.
Ost JA; Newton PW; Neilson DR; Cioffi JA; Wackym PA; Perkins RS
Biopreserv Biobank; 2017 Feb; 15(1):3-8. PubMed ID: 28140617
[TBL] [Abstract][Full Text] [Related]
6. Modifiable risk factors in colorectal surgery: central role of surgeon's volume.
Pata G; Casella C; Nascimbeni R; Cirillo L; Salerni B
Ann Ital Chir; 2008; 79(6):427-32; discussion 432-3. PubMed ID: 19354037
[TBL] [Abstract][Full Text] [Related]
7. Proposed BioRepository platform solution for the ALS research community.
Sherman A; Bowser R; Grasso D; Power B; Milligan C; Jaffa M; Cudkowicz M
Amyotroph Lateral Scler; 2011 Jan; 12(1):11-6. PubMed ID: 21128868
[TBL] [Abstract][Full Text] [Related]
8. [The haematological biobank--an infrastructure for quality assurance, development and research].
Johnsen HE; Pilgaard L; Højfeldt AD; Andersson TL; Schmitz A; Gade KH; Fogd K; Nyegaard M; Bøgsted M; Dybkær K
Ugeskr Laeger; 2011 May; 173(21):1489-93. PubMed ID: 21627910
[TBL] [Abstract][Full Text] [Related]
9. Establishing a cancer center data bank and biorepository for multidisciplinary research.
Ambrosone CB; Nesline MK; Davis W
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1575-7. PubMed ID: 16985014
[TBL] [Abstract][Full Text] [Related]
10. [Establishing the Danish CancerBiobank].
Modin C; Bjerregaard B; Ørntoft T; Høgdall E;
Ugeskr Laeger; 2010 May; 172(19):1446-50. PubMed ID: 20470655
[TBL] [Abstract][Full Text] [Related]
11. Who is responsible for inadequate lymph node retrieval after colorectal surgery: surgeon or pathologist?
Sinan H; Demirbas S; Ersoz N; Ozerhan IH; Yagci G; Akyol M; Cetiner S
Acta Chir Belg; 2012; 112(3):200-8. PubMed ID: 22808760
[TBL] [Abstract][Full Text] [Related]
12. The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.
Renzulli P; Lowy A; Maibach R; Egeli RA; Metzger U; Laffer UT
Surgery; 2006 Mar; 139(3):296-304. PubMed ID: 16546492
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
14. What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer.
Solomon MJ; Pager CK; Keshava A; Findlay M; Butow P; Salkeld GP; Roberts R
Dis Colon Rectum; 2003 Oct; 46(10):1351-7. PubMed ID: 14530674
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for collection and handling of specimens from group breast cancer clinical trials.
Leyland-Jones BR; Ambrosone CB; Bartlett J; Ellis MJ; Enos RA; Raji A; Pins MR; Zujewski JA; Hewitt SM; Forbes JF; Abramovitz M; Braga S; Cardoso F; Harbeck N; Denkert C; Jewell SD; ; ; ; ; ; ; ; ; ; ; ;
J Clin Oncol; 2008 Dec; 26(34):5638-44. PubMed ID: 18955459
[TBL] [Abstract][Full Text] [Related]
16. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
17. [Experience with establishment and operation of a biobank].
Stege A; Hummel M
Pathologe; 2008 Nov; 29 Suppl 2():214-7. PubMed ID: 18712392
[TBL] [Abstract][Full Text] [Related]
18. Assessment of operative risk in colorectal cancer surgery: the Cleveland Clinic Foundation colorectal cancer model.
Fazio VW; Tekkis PP; Remzi F; Lavery IC
Dis Colon Rectum; 2004 Dec; 47(12):2015-24. PubMed ID: 15657649
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with enrollment in cancer genetics research.
Ford BM; Evans JS; Stoffel EM; Balmaña J; Regan MM; Syngal S
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1355-9. PubMed ID: 16835336
[TBL] [Abstract][Full Text] [Related]
20. A concept of a MIABIS based register of biosample collections at the Medical University of Innsbruck.
Hofer P; Fiegl H; Angerer J; Mueller-Holzner E; Chamson M; Klocker H; Steiner E; Hauffe H; Zschocke J; Goebel G
Stud Health Technol Inform; 2014; 205():293-7. PubMed ID: 25160193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
